IV announces construction joint venture

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

IV announces construction joint venture

Intellectual Ventures (IV) has formed a joint venture with CollinsWoerman to commercialise new inventions for the design and construction of mid-rise and high-rise housing from a kit of prefabricated component parts

intellectual20ventures20logo.jpg

The joint venture will be called Innovative Building Technologies (IBT) and will be based in Seattle.

The joint venture is through IV’s Invention Development Fund. The firm said the aim is to develop the intellectual property portfolio supporting a group of inventions related to IBT’s prefabricated component parts building technology and to commercialise the inventions for global markets.

IBT will be the owner of the related patent portfolio and CollinsWoerman and its Sustainable Living Innovations affiliate will have an exclusive licence to deploy the technology in the North American market.

Innovative Building Technologies will find global licensees for the technology in other markets such as China, Japan, and Vietnam.

The first building using the IBT technology is underway in the University District in Seattle, with completion scheduled for year-end. Additional projects are in the advanced stages of planning in San Francisco, Alaska, North Dakota and other locations.

IV has been keen to stress that its inventions and patents are being turned into products, in contrast to its reputation as a patent troll.

In August, the firm revealed that it was reducing its 700 staff by 19%, or 140 people. This followed smaller layoffs of 5% of its staff in February this year.

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article